Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like 3 Biotechs With Bulging Pipelines That Could Also Become Attractive Takeover Targets June 29, 2017 A Look at Gilead's Possible New Drug Strategy May 30, 2017 University of Tubingen Release: Neurosciences: A Stress Test For Men And Women February 5, 2017
